Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patch

The Bayer Group
Business & Industry News Channel
The Bayer Group
Roche
GlaxoSmithKline (GSK)
Boehringer Ingelheim
GlaxoSmithKline (GSK)
Pfizer Inc
Merck KGaA